Investigator-Initiated Trials (IITs): Perspectives from Academia and Industry
CAHON MEMBERS ONLY
Date & Venue
Saturday, May 17, 2025
7:00 - 8:40 pm EDT
Via Zoom - Registration is a two part process. Please register below to receive the Zoom registration.
The Chinese American Hematologist and Oncologist Network's (CAHON) Clinical Research and Industry Committees have organized this virtual seminar to discuss how industry partners and academia can work together to bring forward innovative treatments and therapies. The event will include fundamental training and expert insights into the broader landscape of IITs which will give attendees both the knowledge and the practical tools to initiate their own clinical trials.
Program Agenda
7:00 – 7:05 pm Welcome and Opening Remarks
Liang Deng, MD, PhD - CAHON President, Memorial Sloan Kettering Cancer Center
7:05 – 7:25 pm Tracks of IITs - Cooperative Group/CTEP vs Industry IIT (Academic Perspective)
Tian Zhang, MD, MHS – Chair Clinical Research Committee, UT Southwestern
Jingsong Zhang, MD, PhD – Clinical Research Committee, H Lee Moffitt Cancer Center
7:25 – 7:45 pm IITs - What Concepts Have Traction (Industry Perspective)
Chung-Han Joe Lee, MD, PhD – Industry Committee, Exelixis
Siwen Hu-Lieskovan, MD, PhD - Huntsman Cancer Institute, University of Utah
7:45 – 8:05 pm CTEP and FDA IITs - CTEP for IND & IND Exempt Trials, FDA What Needs IND, What Qualifies for IND Exemption, Who Holds IND, etc.
Helen Chen, MD - NCI CTEP
Ke Liu, MD, PhD – Co-Chair Industry Committee, Marengo Therapeutics
8:05 – 8:35 pm Panel Discussion
Moderators: Jianda Yuan, MD, PhD - Chair Industry Committee, Merck
Tian Zhang, MD, MHS – Chair Clinical Research Committee, UT Southwestern
Panelists: Helen Chen, MD – NCI CTEP
Jerry Huang, MD, PhD, MBA – Industry Committee, MG BioPharma Consulting LLC
Chung-Han Joe Lee, MD, PhD – Industry Committee, Exelixis
Yufeng Li, PHD – Industry Committee, Vivace Therapeutics
Siwen Hu-Lieskovan, MD, PhD - Huntsman Cancer Institute, University of Utah
Ke Liu, MD, PhD – Co-Chair Industry Committee, Marengo Therapeutics
Bo Wang, MD – Co-Chair Clinical Research Committee, Willamette Valley Cancer Institute
Dajun Yang, MD, PhD - Ascentage Pharma
Jingsong Zhang, MD, PhD – Clinical Research Committee, H Lee Moffitt Cancer Center
Lei Zheng, MD, PhD – CAHON Board Chair Elect, Mays Cancer Center, MD Anderson
Pan Zheng, MD, PhD - OncoC4, Inc.
Xiaolin Zhu, MD, PhD - Clinical Research Committee, UCSF
8:35 – 8:40 pm Closing Remarks
Jing-Zhou Hou, MD, PhD - CAHON Board Chair, University of Pittsburgh Medical Center
Organizing Committee
Jianda Yuan, MD, PhD - Chair Industry Committee, Merck
Tian Zhang, MD, MHS - Chair Clinical Research Committee, UT Southwestern
Ke Liu, MD, PhD - Co-Chair Industry Committee, Marengo Therapeutics
Bo Wang, MD - Co-Chair Clinical Research Committee, Willamette Valley Cancer Institute
Ronan Hsieh, MD, MS – Industry Committee, University of Washington Fred Hutchinson Cancer Center
Jerry Huang, MD, PhD, MBA - Industry Committee, MG BioPharma Consulting LLC
Zhaohui Jin, MD – Industry Committee, Mayo Clinic
Feng-ming (Spring) Kong, MD, PhD – Clinical Research Committee, The University of Hong Kong
Oliver Kong, MD – Industry Committee, Chengdu NRT Medtech
Chung-Han Joe Lee, MD, PhD - Industry Committee, Exelixis
Yufeng Li, PhD - Industry Committee, Vivace Therapeutics
Jingsong Zhang, MD, PhD - Clinical Research Committee, H Lee Moffitt Cancer Center
Xiaolin Zhu, MD, PhD - Clinical Research Committee, UCSF